大人の呼吸機能障害の最適な治療:国際デルフィー研究
Janet Bondarenko1,2, Jean Bremner1, Brenda Button2,3
1Respiratory Research@Alfred, Monash University, Melbourne, Australia.
まとめ
呼吸機能障害 (DB) の専門家と患者は,必要不可欠な非薬理学的介入に関するコンセンサスを達成しました. 重要な構成要素は,評価,呼吸再訓練,教育,マニュアル療法,心理療法,生活の質を向上させるための家庭療法などです.
科学分野:
- 呼吸器系薬は呼吸器系薬として使われます.
- リハビリテーション療法 リハビリテーション療法
- 患者中心のケアを患者中心にします.
背景:
- 機能不全の呼吸 (DB) は一般的であり,生活の質に大きな影響を与えます.
- 既存の非薬理学的介入には,重要な構成要素と投与方法に関するコンセンサスが欠けている.
- 効果的なDB治療のためのコア要素を定義する必要性があります.
研究 の 目的:
- DBの非薬理学的介入の重要な構成要素に関する専門家と患者のコンセンサスを達成する.
- これらの介入のための最適な形式と実施方法を決定する.
- 標準化されたDB治療プロトコルの開発に情報を提供するためです.
主な方法:
- 国際専門家と消費者フォーカスグループを巻き込んだ2ラウンドのデルフィープロセス.
- 構成要素の評価を収集するために,Qualtricsを通じて管理されるオンライン調査.
- コンセンサスは,特定の中位数と,ライカートスケールの四分間の範囲によって定義される.
主要な成果:
- 主要な構成要素は,包括的な評価,呼吸再訓練 (バイオフィードバック付き/なし),教育,マニュアルセラピー,心理療法,家庭での実践です.
- 望ましいコンポーネントには,個別化された家庭プログラム,情報素材,再評価が含まれていました.
- 任意のコンポーネントは,個別化された治療方式と運動療法で構成されています.
結論:
- DBの治療に不可欠な5つの介入が確立され,評価と家庭での実践を強調しました.
- 介入の個別化と治療フォーマットが推奨されています.
- 発見は,証拠に基づいた非薬理学的DB治療の開発のための基盤を提供します.
関連する概念動画
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
COPD: Management Using Bronchodilators and Corticosteroids
864
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
864
Acute Respiratory Failure-V
525
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
525
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.3K
Flail Chest-II
697
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
697


